
    
      -  In patients with Stage 2 hypertension to determine the efficacy and safety of
           S-Amlodipine/Telmisartan (2.5/40mg, 2.5/80mg and 5/80mg) or S-Amlodipine monotherapy
           (2.5mg and 5mg) during 10 weeks.

        -  This study is consist of placebo run-in period(2 weeks_single blind) and treatment
           period(10 weeks_double blind.
    
  